Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

NCT06908629 | Recruiting

• 1 other identifier: 2024-042
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are:

• Can we have a completion rate of at least 80% of participants filling out the screening tool?
• Can we determine procedures for patient referrals based on social needs
• Can we implement brief interventions based on food access and digital inclusion (ensuring everyone has access to the digital technologies they need to participate in society)

Conditions

Cancer; Cancer Survivors; Gastrointestinal Cancers; Neuroendocrine Tumors; Multiple Myeloma, Neoplasms

Outcome Measures

Primary Outcomes (1)

• Percentage of participants completing the screening tool

  80% of the 120 participants will complete the American Academy of Family Physicians (AAFP) Social Needs Screening Tool

  At enrollment

Study Arms (1)

Screening Needs Assessment

EXPERIMENTAL

Other: Implementation of social determinants of health screening and referral

Interventions

Implementation of social determinants of health screening and referral OTHER

Participants will be referred to community-based resources in response to their answers on the screening tool.

Screening Needs Assessment

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older
• past or current cancer diagnosis
• reside in metropolitan Detroit (Wayne, Oakland, Macomb counties)
• English proficient
• Actively receiving care through one of Karmano's Cancer Institute's outpatient clinics OR post treatment survivors in the Detroit Research on Cancer Survivors (ROCS) longitudinal cohort study who have reported past food insecurity and agreed to be contacted for further research

You may not qualify if:

• none

Sponsors & Collaborators

• Barbara Ann Karmanos Cancer Institute: lead

Study Sites (1)

Karmanos Cancer Institute

Detroit, Michigan, 48201, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms; Gastrointestinal Neoplasms; Neuroendocrine Tumors; Multiple Myeloma

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

Digestive System Neoplasms; Neoplasms by Site; Digestive System Diseases; Gastrointestinal Diseases; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms, Nerve Tissue; Neoplasms, Plasma Cell; Hemostatic Disorders; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemic and Lymphatic Diseases; Hemorrhagic Disorders; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Professional Practice; Organization and Administration; Health Services Administration

Central Study Contacts

Hayley S Thompson, Ph.D.

CONTACT

313-576-9734; hayley.thompson@wayne.edu

Afsana Rinky

CONTACT

313-576-9734; rinkya@karmanos.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 27, 2025
• First Posted: April 3, 2025
• Study Start: September 3, 2024
• Primary Completion (Estimated): May 1, 2027
• Study Completion (Estimated): May 1, 2027
• Last Updated: August 26, 2025

Record last verified: 2025-08

Locations

US (1)